Mutations in BAP1 can cause various types of cancer, such as renal cell carcinoma and mesothelioma, and when BAP1 is mutated, the inhibition of SLC7A11 and the promotion of ferroptosis are lost (Zhang et al., 2018b). This evidence concerns the gene SLC7A11 and renal cell carcinoma.